Risk of Endophthalmitis in Boston Type 1 Keratoprosthesis Combined with Vitrectomy and Silicone Oil Insertion

被引:6
|
作者
Abou Shousha, Mohamed [1 ,2 ]
Eleiwa, Taher [2 ,3 ]
Gibbons, Allister [2 ]
Smith, Christopher [1 ]
Edelstein, Sean [1 ]
Kontadakis, George [2 ]
Schmitz, Zachary [1 ]
Abernathy, Joshua [1 ]
Chod, Ross [1 ]
Bodnar, Zachary [1 ]
McDaniel, Kelvin [1 ]
Bentivegna, Rocio [1 ]
Akdumanl, Levent [1 ]
机构
[1] St Louis Univ, Eye Inst, St Louis, MO 63103 USA
[2] Bascom Palmer Eye Inst, Miami, FL 33136 USA
[3] Benha Univ, Fac Med, Dept Ophthalmol, Banha, Egypt
关键词
BLEB-RELATED ENDOPHTHALMITIS; VITREORETINAL COMPLICATIONS; TRABECULECTOMY; SPECTRUM; EYES; OUTCOMES; HYPOTONY; SURGERY;
D O I
10.1155/2019/9648614
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. To identify the incidence of endophthalmitis and visual outcomes in eyes with Boston type 1 keratoprosthesis combined with pars plana vitrectomy and silicone oil insertion (KPro+PPV+SOI) as compared to eyes receiving Boston type 1 keratoprosthesis (KPro) alone. Patients and Methods. Retrospective chart review of 29 eyes of 27 patients with KPro having at least 12-month follow-up. Thirteen of these eyes had hypotony and/or retinal detachment in addition to corneal pathology and thus received KPro+PPV+SOI. Polymyxin-trimethoprim with a quinolone was used as chronic topical antibiotic prophylaxis in both groups after the first postoperative month. Outcome measures recorded at the 1-, 3-, 6-, 12-, and 24-month follow-up visits included best-corrected visual acuity (BCVA) and rates of postoperative complications. Results. All the patients had completed 24-month follow-up except one case in the KPro group who lost to follow-up after 12-month visit. In the KPro+PPV+SOI group, no eyes had developed endophthalmitis by the 24-month follow-up visit versus 5 eyes of 5 patients in the uncombined KPro group (P=0.048). The 2-year cumulative endophthalmitis incidence was 31.2% in the KPro group versus zero in the KPro+PPV+SOI group (P=0.030). Four of these 5 eyes had vitreous taps with positive cultures; 2 were positive with Staphylococcus aureus, 1 with coagulase-negative staphylococci, and 1 with Streptococcus pneumoniae. Other complications included KPro extrusion (1 in each group), retinal detachment (2 in the KPro and 1 in the KPro+PPV+SOI group), newly developed glaucoma (2 in each group), and retroprosthetic membrane (9 in the KPro and 5 in the KPro+PPV+SOI group). The KPro group had better average preoperative BCVA compared to those of the KPro+PPV+SOI group (-2.29 +/- 0.72 LogMAR, versus -2.95 +/- 0.30 LogMAR; P = 0.004). No statistically significant difference in BCVA was noted in subsequent follow-up visits. Conclusion. The addition of PPV and SOI to the KPro implantation in the eyes with corneal pathology, as well as hypotony and/or retinal detachment, is a safe and effective procedure for visual rehabilitation. Pars plana vitrectomy and silicone oil insertion may have a protective effect against the development of postoperative endophthalmitis in eyes receiving KPro.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Pars Plana Vitrectomy and Silicone Oil insertion Protect Against Endophthalmitis in Patients with Boston Type 1 Keratoprosthesis
    Abou Shousha, Mohamed
    Schmitz, Zachary
    Abernathy, Joshua
    Chod, Ross
    Bodnar, Zachary
    Bentivegna, Rocio
    Edelstein, Sean
    Akduman, Levent
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [2] Boston Type 1 Keratoprosthesis Combined With Silicone Oil for Treatment of Hypotony in Prephthisical Eyes
    Chan, Clara C.
    Holland, Edward J.
    Sawyer, William I.
    Neff, Kristiana D.
    Petersen, Michael R.
    Riemann, Christopher D.
    CORNEA, 2011, 30 (10) : 1105 - 1109
  • [3] Silicone oil endotamponade in eyes with Boston Keratoprosthesis Type 1
    Schaub, Friederike
    Bachmann, Bjorn O.
    Cursiefen, Claus
    ACTA OPHTHALMOLOGICA, 2022, 100 (04) : E1041 - E1042
  • [4] Pars Plana Vitrectomy and Silicone Oil Injection Combined with Boston Type 1 Keratoprosthesis in Eyes with Retinal Detachment and/or Hypotony and Corneal Opacity
    Chod, Ross
    Bodnar, Zachary
    Abou Shousha, Mohamed
    Akduman, Levent
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [5] The Boston type 1 Keratoprosthesis and endophthalmitis: a systematic review
    Cole, S. T.
    Avadhanam, V. S.
    Liu, C. S. C.
    ACTA OPHTHALMOLOGICA, 2014, 92
  • [6] Review of endophthalmitis following Boston keratoprosthesis type 1
    Robert, Marie-Claude
    Moussally, Krystel
    Harissi-Dagher, Mona
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2012, 96 (06) : 776 - 780
  • [7] Hyperopic refractive error in eyes with Boston Type 1 keratoprosthesis and silicone oil
    Bodnar, Zachary Modest
    Abou Shousha, Mohamed
    Chod, Ross
    Akduman, Levent
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [8] Microbial Keratitis and Endophthalmitis After the Boston Type 1 Keratoprosthesis
    Wagoner, Michael D.
    Welder, Jeffrey D.
    Goins, Kenneth M.
    Greiner, Mark A.
    CORNEA, 2016, 35 (04) : 486 - 493
  • [9] Infectious Endophthalmitis After Boston Type 1 Keratoprosthesis Implantation
    Chan, Clara C.
    Holland, Edward J.
    CORNEA, 2012, 31 (04) : 346 - 349
  • [10] Pars plana vitrectomy through the Boston Keratoprosthesis type 1
    Harissi-Dagher, M.
    Durr, G. M.
    Biernacki, K.
    Sebag, M.
    Rheaume, M-A
    EYE, 2013, 27 (06) : 767 - 769